Provided by Tiger Trade Technology Pte. Ltd.

Genprex, Inc.

3.95
0.0000
Post-market: 3.950.00000.00%19:58 EDT
Volume:96.48K
Turnover:390.69K
Market Cap:3.24M
PE:-0.02
High:4.29
Open:3.90
Low:3.86
Close:3.95
52wk High:1,210.00
52wk Low:3.83
Shares:819.70K
Float Shares:818.70K
Volume Ratio:0.09
T/O Rate:11.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-173.0075
EPS(LYR):-382.7870
ROE:-203.86%
ROA:-94.46%
PB:0.22
PE(LYR):-0.01

Loading ...

Genprex selects manufacturing organization for diabetes gene therapy

TIPRANKS
·
Aug 18

Genprex Signs CDMO Deal to Scale up Manufacturing for Diabetes Gene Therapy Program

Reuters
·
Aug 18

Genprex - Continues to Optimize Constructs and Evaluate Alternative Delivery Approaches

THOMSON REUTERS
·
Aug 18

Genprex - CDMO to Manufacture Aav-Based Therapy for Preclinical Studies and Future Clinical Trials

THOMSON REUTERS
·
Aug 18

Genprex - Transfers Diabetes Product Manufacturing to Cgmp Compliant CDMO

THOMSON REUTERS
·
Aug 18

Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale up of Diabetes Gene Therapy

THOMSON REUTERS
·
Aug 18

Genprex Q2 Net Loss Narrows 5% to $4.45 Million Year over Year

Reuters
·
Aug 14

Genprex Must Keep NASDAQ Bid Price at or Above $1 Through Dec. 7 to Retain Listing

Reuters
·
Aug 06

Genprex Partners with Roche Diagnostics on NSCLC Biomarker Assay Validation Studies

Reuters
·
Aug 03

Genprex - Collaboration to Refine Patient Identification Using Trop2 Biomarker

THOMSON REUTERS
·
Aug 03

Genprex - Expects to Complete Validation Studies by End of 2026

THOMSON REUTERS
·
Aug 03

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

THOMSON REUTERS
·
Aug 03

Genprex trading halted, news pending

TIPRANKS
·
Jul 16

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Jul 16

Genprex says CIPO issues Notice of Allowance for patent

TIPRANKS
·
Jun 22

Genprex wins Canadian patent allowance for Reqorsa combo with PD-1 or PD-L1 antibodies in lung cancer

Reuters
·
Jun 22

Genprex shareholders approve amended 2018 equity incentive plan at annual meeting

Reuters
·
Jun 19

Genprex participates in BIO International Convention 2026

Reuters
·
Jun 17

Genprex - Receives Nasdaq Notice of Non-Compliance With $1 Minimum Bid Price - SEC Filing

THOMSON REUTERS
·
Jun 13

Genprex faces Nasdaq delisting risk after bid price stays below $1

Reuters
·
Jun 13